期刊文献+

SARS Vaccine:Progress and Challenge

SARS Vaccine:Progress and Challenge
原文传递
导出
摘要 Severe acute respiratory syndrome(SARS)emerged in 2002 as a severe and highly contagious infectious disease that rapidly spread to a number of different countries.The collaborative efforts of the global scientific community have provided,within a short period of time,substantial insights into the molecular biology and immunology of SARS-CoV.Although the outbreak has been contained,there is continuous concern that the virus may resurface into the human population through seasonal changes,animal reservoirs or laboratory accidents.The severe morbidity and mortality associated with SARS make it imperative that an effective vaccine be developed to prevent reemergence and epidemics in the future.Cellular & Molecular Immunology.2005;2(2):101-105. Severe acute respiratory syndrome(SARS)emerged in 2002 as a severe and highly contagious infectious disease that rapidly spread to a number of different countries.The collaborative efforts of the global scientific community have provided,within a short period of time,substantial insights into the molecular biology and immunology of SARS-CoV.Although the outbreak has been contained,there is continuous concern that the virus may resurface into the human population through seasonal changes,animal reservoirs or laboratory accidents.The severe morbidity and mortality associated with SARS make it imperative that an effective vaccine be developed to prevent reemergence and epidemics in the future.Cellular & Molecular Immunology.2005;2(2):101-105.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2005年第2期101-105,共5页 中国免疫学杂志(英文版)
关键词 SARS VACCINE animal model immune response CORONAVIRUS emerging infection SARS vaccine animal model immune response coronavirus emerging infection
  • 相关文献

参考文献11

  • 1Huadong Pei,Jingfang Liu,Yun Cheng,Chaomin Sun,Chen Wang,Yueping Lu,Jie Ding,Jian Zhou,Hua Xiang.Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination[J].Applied Microbiology and Biotechnology.2005(2)
  • 2Babcock GJ,Esshaki DJ,Thomas WD Jr,Ambrosino DM.Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor[].Journal of Virology.2004
  • 3Ksiazek TG,Erdman D,Goldsmith CS,et al.A novel coronavirus associated with severe acute respiratory syndrome[].The New England Journal of Medicine.2003
  • 4Shi Y,Wan Z,Li L,et al.Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients[].Journal of Clinical Virology.2004
  • 5Jin H,Xiao C,Chen Z,et al.Induction of Thl type response by DNA vaccinations with N,M,and E genes against SARS-CoV in mice[].Biochemical and Biophysical Research Communications.2005
  • 6Wang R,Epstein J,Baraceros FM,et al.type 1 responses in humans by a malaria DNA vaccine[].Proceedings of the National Academy of Sciences of the United States of America.2001
  • 7Gao W,Tamin A,Soloff A,et al.Effects of a SARS-associated coronavirus vaccine in monkeys[].The Lancet.2003
  • 8Yang Y,Jooss KU,Su Q,Ertl HC,Wilson JM.Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo[].Gene Therapy.1996
  • 9MacGregor RR,Boyer JD,Ugen KE,et al.First human trial of a DNA-based vaccine for treatment of human immunodeficiency vires type 1 infection:safety and host response[].The Journal of Infectious Diseases.1998
  • 10Lee N,Hui D,Wu A,et al.A major outbreak of severe acute respiratory syndrome in Hong Kong[].The New England Journal of Medicine.2003

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部